hotspot -WSS

hotspot

author：focus 2025-08-26 23:46:01 - browse：24

Have you ever seen a mouse with a set of muscles more appropriate for a bodybuilder or comic book superhero?

Well, 25 years ago, researchers at Johns Hopkins University made it happen. By silencing a gene responsible for producing a protein called myostatin, they directed tiny mouse bodies to grow double the amount of lean muscle they would normally, leading to mice with bulky arms, defined pectorals, and an overall more substantial body mass. They were dubbed “mighty mice.”

Now, biotech startups are hoping to use those findings to create what they believe will be better weight loss medications. In the last several months, multiple companies have disclosed they are testing drugs that preserve or grow muscle while reducing fat, as shown in the updated STAT Obesity Drug Tracker. They hope that their drugs, possibly when used in conjunction with existing obesity treatments, will result in healthier weight loss.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Inari Medical to buy amputation prevention company LimFlow

WSS

Medicare proceeds with plan to claw back hospital funds

Readout LOUD podcast: ESMO highlights & Roivant's big deal

In his State of the Union, Biden takes clear aim at 'Big Pharma'

Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

What is microchimerism and how does it affect maternal health?

Readout LOUD podcast: Venture capital turmoil, obesity drug competition

knowledge

hotspot

entertainment

Dobbs anniversary: the lost opportunity of abortion as health care

In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug

Malaria cases in Florida and Texas: Here’s what you need to know

Kidney transplant patients stopped immunosuppressants in trial

Duchenne breakthrough therapy leaves behind pioneering families

In his State of the Union, Biden takes clear aim at 'Big Pharma'

Bright Health sells Medicare Advantage business to Molina

Live blog: Hearing on CRISPR

New air purifier tech could be key to improving indoor air quality

How to bring more disabled researchers into academia

Wikipedia

Readout Newsletter: Amylyx, Alto Neuro, and Eli Lilly for the Oscars

In his State of the Union, Biden takes clear aim at 'Big Pharma'

Explaining an after

Kidney transplant patients stopped immunosuppressants in trial

First medicine developed to treat MASH expected to be approved soon

Just how do doctors, lawmakers, and the public define abortion?

entertainment

hotspot

explore

hotspot